MarketCap
Facebook
X
Telegram
Novo Integrated Sciences Revenue | NVOS
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Novo Integrated Sciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.3 M | 12.6 M | 11.7 M | 9.31 M | 7.86 M | 9.42 M | 8.89 M | 7.96 M | 7.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.3 M | 7.18 M | 9.8 M |
Quarterly Revenue Novo Integrated Sciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.15 M | 3.17 M | 3.89 M | 3.89 M | 3.29 M | 2.56 M | 3.42 M | 3.42 M | 13.9 M | 2.87 M | 3.16 M | 3.16 M | 2.38 M | 2.08 M | 2.16 M | 2.16 M | 1.04 M | 2.43 M | 2.55 M | 2.55 M | 2.49 M | 2.2 M | 2.31 M | 2.31 M | 2.32 M | 2.15 M | 2.25 M | 2.25 M | 2.09 M | 2.09 M | 1.83 M | 1.82 M | - | 1.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.9 M | 1.04 M | 2.88 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Care facilities industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Мать и Дитя
MDMG
|
25.2 B | - | - | - |  Russia |
|
Sanara MedTech
SMTI
|
103 M | $ 35.05 | 0.92 % | $ 302 M |  USA |
 |
Tenet Healthcare Corporation
THC
|
21.3 B | $ 259.06 | 0.59 % | $ 23.4 B | USA |
 |
Surgery Partners
SGRY
|
3.31 B | $ 13.96 | 0.64 % | $ 1.78 B | USA |
 |
Universal Health Services
UHS
|
17.4 B | $ 171.89 | 1.32 % | $ 10.9 B | USA |
 |
U.S. Physical Therapy
USPH
|
781 M | $ 78.71 | 0.9 % | $ 1.19 B | USA |
 |
Amedisys
AMED
|
2.35 B | - | 0.01 % | $ 3.3 B | USA |
 |
Hanger
HNGR
|
1.12 B | - | - | $ 732 M | USA |
 |
Ontrak
OTRK
|
10.8 M | - | -11.98 % | $ 1.53 M | USA |
 |
Acadia Healthcare Company
ACHC
|
3.31 B | $ 27.5 | 0.21 % | $ 2.49 B | USA |
 |
Tivity Health
TVTY
|
127 M | - | 0.09 % | $ 1.6 B | USA |
 |
LHC Group
LHCG
|
2.28 B | - | - | $ 5.27 B | USA |
 |
Addus HomeCare Corporation
ADUS
|
1.42 B | $ 119.32 | 0.47 % | $ 2.15 B | USA |
 |
AMN Healthcare Services
AMN
|
2.73 B | $ 33.73 | 0.09 % | $ 1.3 B | USA |
 |
American Shared Hospital Services
AMS
|
28.1 M | $ 1.42 | 0.33 % | $ 9.39 M | USA |
 |
Capital Senior Living Corporation
CSU
|
384 M | - | -2.09 % | $ 216 M | USA |
 |
Brookdale Senior Living
BKD
|
3.19 B | $ 12.09 | 2.72 % | $ 2.84 B | USA |
|
New Frontier Health Corporation
NFH
|
2.26 B | - | 3.54 % | $ 1.5 B | USA |
|
Aesthetic Medical International Holdings Group Limited
AIH
|
902 M | - | 10.96 % | $ 46.2 M |  China |
 |
Concord Medical Services Holdings Limited
CCM
|
461 M | $ 4.35 | 5.05 % | $ 570 M | China |
 |
Five Star Senior Living Inc.
FVE
|
1.16 B | - | -0.32 % | $ 98.4 M | USA |
 |
Chemed Corporation
CHE
|
2.53 B | $ 519.01 | 0.42 % | $ 7.47 B | USA |
 |
Community Health Systems
CYH
|
12.5 B | $ 2.84 | 0.34 % | $ 379 M | USA |
 |
DaVita
DVA
|
13.6 B | $ 180.06 | 1.28 % | $ 13.4 B | USA |
 |
Encompass Health Corporation
EHC
|
5.94 B | $ 120.47 | 0.01 % | $ 12.1 B | USA |
 |
Elanco Animal Health Incorporated
ELAN
|
4.72 B | $ 23.97 | 0.33 % | $ 11.9 B | USA |
 |
The Ensign Group
ENSG
|
5.06 B | $ 170.54 | 0.4 % | $ 9.77 B | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
19.6 B | $ 22.45 | 0.04 % | $ 6.54 B |  Germany |
 |
HCA Healthcare
HCA
|
75.6 B | $ 402.02 | 0.57 % | $ 95 B | USA |
 |
Healthcare Services Group
HCSG
|
1.84 B | $ 21.78 | 0.05 % | $ 1.58 B | USA |
 |
The Joint Corp.
JYNT
|
15.2 M | $ 8.19 | 0.48 % | $ 124 M | USA |
 |
MEDNAX
MD
|
1.91 B | $ 26.94 | 0.56 % | $ 2.27 B | USA |
 |
National HealthCare Corporation
NHC
|
1.52 B | $ 220.97 | 1.07 % | $ 3.42 B | USA |
 |
Option Care Health
OPCH
|
5.65 B | $ 23.74 | 2.56 % | $ 3.85 B | USA |
 |
Phibro Animal Health Corporation
PAHC
|
1.52 B | $ 37.31 | 0.06 % | $ 1.51 B | USA |
 |
The Pennant Group
PNTG
|
948 M | $ 39.31 | 3.45 % | $ 1.36 B | USA |
 |
Oak Street Health
OSH
|
578 M | - | 0.03 % | $ 9.53 B | USA |
 |
Genesis Healthcare, Inc.
GEN
|
3.91 B | - | - | $ 68.1 M | USA |
 |
Avalon GloboCare Corp.
AVCO
|
1.33 M | - | 26.45 % | $ 70.6 M | USA |
 |
Apollo Medical Holdings
AMEH
|
3.18 B | - | -2.11 % | $ 1.84 B | USA |
 |
IMAC Holdings
IMAC
|
72 K | - | -1.77 % | $ 25.4 M | USA |
 |
ModivCare
MODV
|
2.79 B | - | -25.23 % | $ 6.12 M | USA |
 |
Regional Health Properties
RHE
|
53.2 M | - | - | $ 5.2 M | USA |
 |
Select Medical Holdings Corporation
SEM
|
5.45 B | - | - | $ 2.02 B | USA |
 |
SunLink Health Systems
SSY
|
32.4 M | - | 17.98 % | $ 7.81 M | USA |